Product Information：
- Product name: Gilteritinib 40mg
- Manufacturer / brand: Laos Alliance
- Active ingredient: Gilteritinib
- Current strength:40mg
- SKU: 1-L-1234
- Site category: FLT3 target, other cancer
Active Ingredient and Reference Data
Gilteritinib is the active ingredient used for this product page. Public prescribing information for Gilteritinib was used for the medical reference sections. Medical details are provided for reference and must be interpreted by a qualified healthcare professional.
Mechanism of Action
Gilteritinib (Xospata) is an oral dual FLT3/AXL inhibitor that blocks both FLT3-ITD and FLT3-TKD mutant signaling, inducing apoptosis in leukemic cells to treat relapsed/refractory FLT3-mutant AML.
Storage and Purchase Notes
Store according to the package or pharmacist instructions and keep out of reach of children. Before ordering, confirm product name, strength, quantity, price, shipping details, and payment method. After receipt, check packaging, batch number, expiration date, and storage conditions.
Reviews
There are no reviews yet.